In France, in 2019, OOP expenditures to manage psoriasis were on average more than twice as high as the overall mean health-related OOP expenditures estimated by the French Health Agency in 2018. These results should lead health authorities to review certain standards of healthcare reimbursement. Lien vers l'article
RICHARD, M., PAUL, C., PUYOU DE POUVOURVILLE, G., JULLIEN, D., MAHE, E., BACHELEZ, H. ... EZZEDINE, K. (2021). Out‐of‐pocket expenditures in France to manage psoriasis in adult patients: results from an observational, cross‐sectional, non‐comparative, multicentre study. Journal of the European Academy of Dermatology and Venereology, 35(4), pp. 912-918.